Feedback / Questions
tarextumab (OMP-59R5) - MorphoSys, Mereo Biopharma, GSK
OncoMed: BIO Investor Forum
(OncoMed)
-
Oct 18, 2014 -
"Tarextumab Phase 1b ALPINE Pancreatic Cancer Response Data"
P1 data
•
Oncology • Pancreatic Cancer
http://www.veracast.com/bio/investorforum2014/main/events/1061_oncome/pdf/OncoMed_Pharmaceuticals.pdf
Oct 18, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.